The North America radiation therapy market size surpassed USD 2.86 billion in 2025 and is predicted to reach around USD 6.41 billion by 2035, registering a CAGR of 8.4% from 2026 to 2035. AI-powered treatments are automating planning and enabling adaptive radiotherapy, and high-precision delivery systems are allowing for higher doses to tumors.

North America Radiation Therapy Market Statical Scope

The American Society for Radiation Oncology (ASTRO) launched a national program, aiming to create authorized user training centers for physicians who are dedicated to offering radiopharmaceutical therapy . This new initiative is introduced to increase the number of physicians who are certified to offer the safe delivery of the emerging cancer treatments. This program also aims to expand patient access in support of the Novartis Pharmaceuticals Corporation.

The increasing number of radiopharmaceutical agents entering clinical practice raised the demand for qualified clinicians. The leading companies, like Novartis, aim to boost the safe adoption of novel radiopharmaceutical treatments for people with cancer.

North America Radiation Therapy Market, By Type 2025 (%)

• Product - The product segment dominated the market with a share of 70.00%, owing to higher demand for linear accelerators, robotic radiosurgery, proton therapy systems, and many others. The potential manufacturers of these products are GE Healthcare, Elekta, Varian, Mirion Technologies, and CQ Medical.
• Service - The service segment held a 30.00% share and is expected to grow in the coming years, driven by the increasing need for specialized treatment care. There is a great role for physicists and radiation oncologists in ensuring safe and accurate treatment delivery.

North America Radiation Therapy Market, By Technology 2025 (%)

• External Beam Radiotherapy - The external beam radiotherapy segment dominated the market with a share of 45.00% due to its widespread use and effectiveness in treating various cancers. It is a common form of radiation therapy treatment used to treat lung cancer, colon cancer, breast cancer, etc.
• Conventional Cobalt - 60 Teletherapy Units- The conventional cobalt-60 teletherapy units segment held a share of 20.00% and is expected to grow in the coming years, driven by its importance as a cost-effective option. These units are valued for their lower maintenance, suitability for palliative care, and ruggedness.

North America Radiation Therapy Market, By Procedure 2025 (%)

• External Beam Radiotherapy - The external beam radiotherapy segment dominated the market with a share of 50.00% due to its widespread usage in clinical settings and applicability in various cancer treatments. This procedure is renowned for its non-invasive and painless nature.
• Internal Beam Radiotherapy/Brachytherapy - The internal beam radiotherapy/brachytherapy segment held a 30.00% share and is expected to grow in the coming years due to its precision. This procedure has potential applications for prostate cancer, cervical cancer, etc. It involves a computerized machine to control the delivery of radioactive sources through catheters.

North America Radiation Therapy Market, By End-User 2025 (%)

• Hospitals - The hospitals segment dominated the market with a 75.00% share due to their extensive treatment capabilities and infrastructure. Radiation therapy is an integral part of modern cancer care in hospitals. It eliminates tumors in early-stage cancers through a curative treatment.
• Independent Radiotherapy Centers - The independent radiotherapy centers segment held a 25.00% share and is expected to grow in the coming years due to the growing trend of outsourcing radiation therapy services. Independent centers prioritize advanced and targeted technologies to enhance tumor destruction.

Top Companies in the North America Radiation Therapy Market

• Nordion Inc
• Siemens healthcare
• Mevion medical system, Inc
• Isoray, Inc, Icad, Inc
• Becton Dickinson and Company
• Ion Beam Appications SA
• Elekta AB
• Eckert & Zeigler Group
• Accuray Incorporated
• Varian Medical Syatems, Inc
• NTP Radioisotopes SOC Ltd
• Curium Pharma, C.R.BARD , Inc
• IBA Radiopharma Solutions
• ViewRay, Inc
• P-cure Ltd
• ZEISS Group
• Panacea Medical Technologies
• Hitachi Ltd

Segments Covered in the Report

By Type

• Product
• Service

By Technology

• External Beam Radiotherapy
• Conventional Cobalt-60 Teletherapy Units
• Particle Therapy Systems
• Internal Beam Radiotherapy/Brachytherapy
• Systemic Radiotherapy

By Procedure

• External Beam Radiotherapy
• Internal Beam Radiotherapy/Brachytherapy
• Oral Radiotherapy
• Intravenous Radiotherapy
• Systemic Radiotherapy
• Instillation Radiotherapy

By End-User

• Hospitals
• Independent Radiotherapy Centers